News
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
Long Island patients lost vision after taking weight loss drugs Ozempic and Wegovy, lawsuits contend
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
A pragmatic approach to streamlining technology and innovating processes will help advance clinical data management.
South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...
With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...
Explore Viking's innovative GLP-1/GIP & THR-β therapies, with strong Phase 2/3 results, targeting major markets with ...
The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 20, 2025 /PRNewswire/ -- Equity Insider News Commentary - The World Economic ...
Not bad for having to sit through a few prolonged talkfests during which the EU simply held out until the British caved in – ...
Compounding pharmacies are supposed to stop producing the compounded versions of the popular weight loss medications now that ...
18h
Medpage Today on MSNGLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data ShowCognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results